UPDATE 1-Shareholder asks Office Depot to revoke poison pill
Nov 16 (Reuters) - Activist hedge fund Starboard Value asked Office Depot Inc to immediately revoke its "poison pill" provision, claiming it limited the influence of shareholders.
In September, Starboard said it took a 13.3 percent stake in Office Depot, the No. 2 U.S. office supply retailer, making it the biggest shareholder in the company. On Friday, the hedge fund said it owned a 14.8 percent stake.
"We believe the implementation of the poison pill, with a threshold just above our current ownership, is designed specifically to entrench the current board," Starboard said in a letter to the board.
Office Depot has been facing tough competition from other office products suppliers as well as mass merchants and drugstores.
Sales at office supply retailers have suffered as corporate customers and other shoppers cut back on discretionary spending in the weak global economy.
Same-store sales at Office Depot's 1,090 North American stores fell 4 percent in the third quarter.
Office Depot shares closed at $2.96 Thursday on the New York Stock Exchange.
- Police seek motive in fatal Washington state school shooting
- Two deputies killed, two others hurt in California shooting spree
- Wall St. finally turning on Amazon as Bezos magic fades
- Iran hangs woman convicted of killing alleged rapist
- Medical worker quarantined in New Jersey under new Ebola safeguards |